Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.97
+0.44 (4.18%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Design Therapeutics Employees
Design Therapeutics had 54 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
54
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,290,981
Market Cap
685.15M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 54 | 0 | - | 54 | 0 |
| Dec 31, 2025 | 54 | 0 | - | 54 | 0 |
| Dec 31, 2024 | 54 | -4 | -6.90% | 54 | 0 |
| Dec 31, 2023 | 58 | 0 | - | 58 | 0 |
| Dec 31, 2022 | 58 | 20 | 52.63% | 58 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| CorMedix | 191 |
| Omeros | 175 |
| Allogene Therapeutics | 152 |
| Solid Biosciences | 121 |
| Aura Biosciences | 113 |
| CytomX Therapeutics | 69 |
| Oculis Holding AG | 60 |
DSGN News
- 10 days ago - Design Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 17 days ago - Design Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 27 days ago - Design Therapeutics Transcript: Status update - Transcripts
- 27 days ago - Design Therapeutics Press release: Status update - Filings
- 27 days ago - Design Therapeutics Slides: Status update - Filings
- 27 days ago - Design Therapeutics announces biomarker, clinical data from RESTORE-FA trial - TheFly
- 27 days ago - Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia - GlobeNewsWire
- 4 weeks ago - Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich's Ataxia on Monday, May 18, 2026 - GlobeNewsWire